overall survival
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
overall survival
Oct 6, 2024, 12:22 |
Insight
Stephen V Liu: Randomized phase II trial results on amrubicin vs cisplatin for SCLC
Stephen V Liu posted the following on X: “Randomized phase II: 1L amrubicin + irinotecan…
Sep 24, 2024, 13:31 |
Blog
Sabine D. Brookman-May: MA supports EFS as a surrogate for OS in Muscle invasive bladder cancer after neoadjuvant treatment
Sabine D. Brookman-May shared a post on X: ''This MA supports Event-free survival as a…
Sep 22, 2024, 17:46 |
Blog
Francisco J. Esteva: KEYNOTE-522 Trial Shows Pembrolizumab Boosts Survival in Triple-Negative Breast Cancer
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital, posted the…
Sep 17, 2024, 16:37 |
Blog
Erika Hamilton: KN522 OS data shows 5% overall survival improvement in TNBC with pembrolizumab
Erika Hamilton posted the following on Twitter: “KN522 OS data 5 years after the initial pCR…
Sep 17, 2024, 16:15 |
Blog
Median overall survival in melanoma with nivolumab plus ipilimumab presented at ESMO24 - NEJM
NEJM posted the following on X: “Presented at ESMO24: Among patients with advanced melanoma, median…
Jul 25, 2024, 08:28 |
Blog
Recommendations to improve using Overall Survival data to inform benefit-risk assessments - FDA Oncology
FDA Oncology posted on X about recent paper by Lisa Rodriguez et al., commenting: "In…
Jul 25, 2024, 00:17 |
Blog
How to improve collection and analysis of Overall Survival data in oncology clinical trials - AACR
AACR (American Association for Cancer Research) shared on LinkedIn: "A recent perspective paper in Clinical…
Jul 3, 2024, 02:46 |
Blog
Malak Alharbi: Stephen V. Liu discusses treatment algorithm for early-stage NSCLC
Malak Alharbi, Hematology/Oncology Fellow at Roswell Park, made the following post on X: "Dr. Stephen…
Jun 30, 2024, 13:53 |
Insight
Long-Term Outcomes From Prostate Cancer Active Surveillance
Avirup Guha, Director of Cardio-Oncology at Georgia Cancer Center, shared on X: …
Jun 29, 2024, 17:42 |
Blog
Fantastic updates about treating intermediate-risk neuroblastoma - St. Baldrick’s Foundation
St. Baldrick’s Foundation shared a post on LinkedIn: Exciting Update on Neuroblastoma Treatment! Researchers involved in…
Jun 29, 2024, 13:39 |
Insight
Myeloma Paper of the Day, June 29th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Real-world analysis of renally impaired…
Jun 28, 2024, 14:34 |
Blog
María Natalia Gandur Quiroga: Imfinzi Shows Significant Survival Benefits in NIAGARA Phase III Trial
María Natalia Gandur Quiroga shared on LinkedIn: . "Imfinzi Shows Significant Survival Benefits in NIAGARA…
Jun 27, 2024, 02:53 |
Blog
Tanja Obradovic: Tempest Therapeutics just announced very good results from ongoing global clinical study with Amezalpat
Tanja Obradovic shared on LinkedIn: . “Are we to expect completely new mechanism of action…
Jun 27, 2024, 02:23 |
Blog
Sarah Adly: Our Article on 'Optimizing Outcomes in Advanced Renal Cell Carcinoma'
Sarah Adly, NCODA Fellow in Oncology, made the following post on LinkedIn: .…
Jun 26, 2024, 14:10 |
Blog
Maria Babak: Rapid Progress in Metastatic Urothelial Carcinoma
Maria Babak shared a post by The Babak Lab on LinkedIn: “The FDA's approval of…
Jun 24, 2024, 23:11 |
Blog
Chandler Park: Superb discussion of the TRANSMET study presented at ASCO24 by Cathy Eng
Chandler Park shared on X: “Dr. Cathy Eng provides a superb and thoughtful discussion of…
Jun 22, 2024, 05:04 |
Blog
Yüksel Ürün: Carboplatin plus docataxel for patients with biallelic HRR gene alterations in metastatic castration-resistant prostate cancer
Yüksel Ürün shared a post on X: “The ABCD Trial shows promising results with carboplatin…
Jun 21, 2024, 06:47 |
Insight
Filippo Montemurro: Not all pCR are made equal
Filippo Montemurro, Senior Medical Director at F. Hoffmann La Roche, shared a post on X: "Impact…
Jun 19, 2024, 03:11 |
Insight
Andres Rodriguez Mignola: SBRT in Oligometastatic Disease in Gynecologic Tumors - A Therapeutic Option?
Andres Rodriguez Mignola, Radiation Oncologist at Ángel Roffo Institute of Oncology, shared a post on…
Jun 15, 2024, 13:48 |
Insight
Myeloma Paper of the Day, June 15th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Natural killer cells with adhesion…
Jun 10, 2024, 15:00 |
Blog
Sumanta K. Pal: PIVOT09 comparing pegylated IL2/nivolumab to TKI by Nizar Tannir et al.
Sumanta K. Pal shared a post on X: “Huge congrats to Nizar Tannir, MD Anderson Cancer…
Jun 10, 2024, 10:31 |
Opinion
Armando Orlandi: To explain the unexplainable in MONARCH 3
Armando Orlandi, Medical Oncologist at Agostino Gemelli University Policlinic, made the following post on X:…
Jun 7, 2024, 13:10 |
Opinion
Paolo Tarantino: Among the ASCO24 abstracts, particularly notable was the DB03 update
Erika Hamilton shared Paolo Tarantino's post on X, adding: , "Agree, I…
Jun 4, 2024, 16:28 |
Societies
Erika Hamilton: Data that pCR translates to outcome in TNBC
Erika Hamilton shared a post on X: “PEARLY: Adriamycin Cyclophosphamide (AC) to Taxane versus AC…
Jun 4, 2024, 04:06 |
Blog
Jun Gong: Dr. Martijn Meijerink's Phase III COLLISION trial less than 10 colorectal liver metastases
Jun Gong, Medical oncologist and researcher in gastrointestinal and genitourinary cancers at Cedars-Sinai, shared a post…
May 29, 2024, 12:51 |
Insight
Julie Hallet: New study on NETs liver metastases from unknown primary by Patrick Starlinger and team Mayo Clinic
Julie Hallet, Pancreatic and Gastrointestinal Surgical Oncologist at IHPBA, shared a post on LinkedIn: “New study…
May 29, 2024, 04:59 |
Blog
Estela Rodriguez: Patients excluded from most clinical trials does not help us find solutions with Leptomeningeal disease
Estela Rodriguez shared a post by EGFR Resisters on X/Twitter: "Leptomeningeal disease - is one of…
May 26, 2024, 16:38 |
Blog
Zouina Sarfraz: Two of my abstracts have been published for the 2024 ASCO Annual Meeting
Zouina Sarfraz, Associate Editor at BMC, shared a post on LinkedIn: "I am pleased to announce…
May 20, 2024, 14:02 |
Blog
Talha Badar: Rx of Lower risk MDS, non del 5q, failing ESA/luspatercept
Talha Badar, Assistant Professor at Mayo Clinic Comprehensive Cancer Center shared a thread on X:…
May 18, 2024, 01:12 |
Opinion
Results from the IMpassion132 trial presented at ESMO Breast 24
The European Society for Medical Oncology (ESMO) shared on LinkedIn: “Results from the IMpassion132 trial presented…
May 12, 2024, 13:31 |
Blog
Stephen Liu: Update from phase 3 IMscin001 trial JTO and JTO CRR
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter: “Update from…
Apr 28, 2024, 10:18 |
Blog
Stephen Liu: Interesting look at immediate versus deferred systemic therapy in patients with pleural mesothelioma at Clinical Lung Cancer
Stephen Liu, Director of Thoracic Oncology and Developmental Therapeutics at Georgetown University, shared on X/Twitter: "Certainly confounders…
Apr 7, 2024, 11:53 |
Insight
Roberto Leon-Ferre: The role of immune activation on the prognosis of early TNBC if chemo is not given?
Roberto Leon-Ferre, Assistant Professor at Mayo Clinic, shared on X/Twitter: "What is the role of…
Feb 25, 2024, 14:57 |
Blog
Robert Francomano: Significant change in regulatory priorities by the FDA
Robert Francomano, Chief Commercial Officer at SELLAS, shared on LinkedIn: "The recent emphasis by the…
Dec 10, 2023, 16:59 |
Insight
Yüksel Ürün: MFS continues to be a reliable predictor for overall survival
Yüksel Ürün, Medical Oncologist at Ankara University, shared on X: “With better access to docetaxel…
All:
35
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube